Page 407 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C3.1 Studies on offer, acceptance, and adherence of active surveillance (continued)
Factors examined Author Study approach AS/WW definitions Findings Issues
Year
PMID
Physician Ramsey 182 Survey of 238 men (multi-center) AS (not explicitly • Urologists recommended • Cannot establish
factors affecting 2011 with newly dx’d localized T1-3 provided) 0.52 more treatment options (SE causality for more RP
offer 20959991 disease and 25 urologists 0.19, P <0.001) in initial recommended by
concerning their office encounters consultation than in second urologists; plausible that
(initial consultation vs. second opinion visit patients sought out
opinion); survey of patients and • For low risk disease, 25% urologists for a second
their urologist in urology clinics in 3 urologists recommended AS, opinion because the
states (Family And Cancer Therapy 77% recommended RP in initial patients were more
Selection study, Charleston, SC; consultation; 16% urologists interested in RP
Los Angeles, CA; San Antonio, Tx); recommended AS, 91% • Applicability limited to
pt recruitment occurred at the recommended RP in second patients/urologists in
urology clinics; 423 invited, 240 met opinion visit academic centers
eligibility criteria; 238 analyzed (2 • Discrepancy between what
excluded for unspecified physicians recommended and
consultation type) what patients heard physicians
recommended: in patients for
whom urologists recommended
RP, 67% patients heard the
recommendation; in patients for
whom urologists recommended
RT or ADT, ~25% patients heard
the recommendation
Physician Steginga 192 Interview of 108 men with newly WW (not explicitly • Unprompted recall of their • Limited applicability to
factors affecting 2002 dx’d localized prostate cancer from provided) urological consultation: 71% of US
offer 11856106 2 hospital clinics and 4 urology the physicians discussed WW;
practices in Queensland, Australia; 92% discussed RP, and 87%
men were referred by their discussed RT
urologists to the project if they have
localized disease (no metastatic
disease on scans and X-rays)
suitable for curative treatment; 131
consecutive men were referred;
119 eligible (newly dx’d localized
disease, communicate in English;
no head injury, dementia,
concurrent psychiatric illness and
cancer), 108 participated

C-121